View All In Series
Published on May 11, 2021
What Is the STOMP Clinical Trial?
In this Multiple Myeloma Ask the Expert segment, Patient Power co-founder and patient advocate Andrew Schorr talks to Dr. Clifton Mo, MD, Medical Oncologist and Director of Autologous Stem Cell Transplantation for Multiple Myeloma at the Dana-Farber Cancer Institute, about the Selinexor and Backbone Treatments of Multiple Myeloma Patients (STOMP) clinical trial. It is a Phase I/Phase II trial utilizing selinexor (Xpovio) in multiple triplet combination therapies.